Share :

partage facebook
partage twitter
partage linkedin

In a smiling, friendly and nevertheless studious atmosphere, Anne-Sophie DEGRYSE hands over the reins to Betty BOURGES as General Manager France at DIAGAST.

Anne-Sophie’s professional background

After 9 years as GM France at DIAGAST, Anne-Sophie Degryse is promoted to the position of GM – Western Europe: she therefore entrusts the keys to her department to Betty Bourges, recruited for the occasion.

As GM France, Anne-Sophie mobilized herself on a daily basis for customer satisfaction, their personalized support, and adapted support that was always in line with the changing challenges of the health system. It is also committed to developing and improving the skills of its teams to achieve these objectives.

In addition, involved in SIDIV (Syndicate of the In Vitro Diagnostics Industry), she was elected vice-president in 2020, to promote the essential role and value of in vitro diagnostics in the patient care pathway.

It was only natural that DIAGAST offered her an international career development.

With her experience for many years in marketing-export, Anne-Sophie has the skills and resources to take up this new challenge.

It is not without nostalgia that I leave France, but it is with great enthusiasm that I turn to the international and its new challenges.

Anne-Sophie DEGRYSE
Anne-Sophie and Betty

Betty’s professional background

Betty has spent her entire career in the field of biological diagnostics with an obvious commercial focus: Business Engineer, Key Account Manager at AP-HP, Director of Sales and Laboratory Engineering then Director of the Medical Biology Division in a large international group, she acquired during her career, beyond an expertise in sales, an in-depth knowledge of the French market, a strong experience in the management of teams and the reinforcement of the corporate culture.

Today, she is committed to integrate the challenges of the care pathway‘s evolution and to contribute to the development of DIAGAST, its people and its customers.

“I take great pleasure in experiencing the medical biology market transformation which drives us to constantly reinvent ourselves in terms of offer, organization and digitalization. It is today with enthusiasm that I join DIAGAST for its new challenges.”


The DIAGAST teams send their best wishes to the 2 new directors for success in their new assignments.

Because receiving blood is receiving life, transfusion should be completely safe everywhere.  DIAGAST revolutionized the Immunohematology field in 2004 by magnetizing red blood cells thanks to its breakthrough E.M.® Technology and continues to innovate all around the world. Our teams support biologists and blood banks for making rapid and optimal decisions, so that the patients have a safe blood transfusion. Built on our unique cell heritage, our diagnostic solutions, either manual or automated, are associated with our high-performance lab software. They allow enhancing patients’ outcome and also increase organizational efficiency while reducing costs for laboratories..Therefore, DIAGAST goes hand in hand with laboratories to shape the future while facing new challenges